AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Jupiter Neurosciences, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG0130XFPG0
2.98▲ 0.40 (15.50%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
2.58
Day's Range
2.58 – 3.22
52-Week Range
0.07 – 11.20
Volume
19.6K
Avg Volume
69.8K
Share Statistics
Shares Outstanding
Employees
5
Exchange
XNAS
Listed
2024-12-03
Share count as of August 14, 2026

Jupiter Neurosciences, Inc. Common Stock (JUNS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Jupiter Neurosciences, Inc. Common Stock (JUNS)
What is Jupiter Neurosciences, Inc. Common Stock's Market Cap?
Jupiter Neurosciences, Inc. Common Stock's Market Cap is $2.3M, based on as-reported figures from SEC (XBRL) filings.
What is Jupiter Neurosciences, Inc. Common Stock's Enterprise Value?
Jupiter Neurosciences, Inc. Common Stock's Enterprise Value is $773.0K, based on as-reported figures from SEC (XBRL) filings.
What is Jupiter Neurosciences, Inc. Common Stock's Price / Sales?
Jupiter Neurosciences, Inc. Common Stock's Price / Sales is 35.5×, based on as-reported figures from SEC (XBRL) filings.
What is Jupiter Neurosciences, Inc. Common Stock's EV / Revenue?
Jupiter Neurosciences, Inc. Common Stock's EV / Revenue is 11.9×, based on as-reported figures from SEC (XBRL) filings.
What is Jupiter Neurosciences, Inc. Common Stock's Revenue (TTM)?
Jupiter Neurosciences, Inc. Common Stock's Revenue (TTM) is $64.7K, based on as-reported figures from SEC (XBRL) filings.
What is Jupiter Neurosciences, Inc. Common Stock's Net Income (TTM)?
Jupiter Neurosciences, Inc. Common Stock's Net Income (TTM) is -$9.2M, based on as-reported figures from SEC (XBRL) filings.
What is Jupiter Neurosciences, Inc. Common Stock's Diluted EPS (TTM)?
Jupiter Neurosciences, Inc. Common Stock's Diluted EPS (TTM) is -11.95, based on as-reported figures from SEC (XBRL) filings.
What is Jupiter Neurosciences, Inc. Common Stock's Net Debt?
Jupiter Neurosciences, Inc. Common Stock's Net Debt is -$1.5M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · JUNSAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
Revenue——
Cost of Revenue——
Gross Profit——
% of revenue86.9%76.6%——
Expenses:
Research and Development Expense
Selling, General and Administrative Expense
Total operating expenses
% of revenue11400.3%10601.0%——
Operating loss
% of revenue-11313.4%-10524.3%——
Other income (expenses):
Interest and Dividend Income (Non-Bank)—
Non-Operating Income (Expense)——
Interest expense
Total other income (expenses), net
Net loss
% of revenue-9380.9%-11054.9%——